NCT01647360 Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment Status COMPLETED Phase N/A
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) Status COMPLETED Phase PHASE2
NCT01634464 Role of Nutrition and Maternal Genetics on the Programming of Development of Fetal Adipose Tissue Status UNKNOWN Phase N/A
NCT01631227 Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension Status COMPLETED Phase PHASE3
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Status UNKNOWN Phase PHASE3
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis Status TERMINATED Phase NA
NCT01605721 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry) Status UNKNOWN Phase PHASE4
NCT01602822 Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV Status TERMINATED Phase PHASE4
NCT01562951 Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants Status TERMINATED Phase PHASE3
NCT01562613 A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With Eprosartan Status COMPLETED Phase N/A
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT01525563 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, Observational Study Status COMPLETED Phase N/A
NCT01506934 A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT01495351 Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma Status COMPLETED Phase PHASE1